Showing results (51-60 of 580) with videos related to

Sort By:
Pageof 58
Dalton Transactions (Cambridge, England : 2003)|November 29, 2005
Design and synthesis of site directed maleimide bifunctional chelators for technetium and rheniumSangeeta Ray Banerjee, Paul Schaffer, John W Babich, et al.
Frontiers in Oncology|September 3, 2019
CXCR4-Directed Imaging in Solid TumorsRudolf A Werner, Stefan Kircher, Takahiro Higuchi, et al.
Molecular Imaging|January 6, 2022
The Number of Frames on ECG-Gated 18F-FDG Small Animal PET Has a Significant Impact on LV Systolic and Diastolic Functional ParametersChristoph Eissler, Rudolf A Werner, Paula Arias-Loza, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2022
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-upPhilipp E Hartrampf, Anna Katharina Seitz, Franz-Xaver Weinzierl, et al.
Theranostics|January 8, 2019
The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?Rudolf A Werner, Alexander Weich, Malte Kircher, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate CancerWajahat Khatri, Hyun Woo Chung, Rudolf A Werner, et al.
Annals of Nuclear Medicine|March 17, 2019
18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studiesSara Sheikhbahaei, Krystyna M Jones, Rudolf A Werner, et al.
Clinical Nuclear Medicine|April 19, 2022
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and TherapySebastian E Serfling, Philipp E Hartrampf, Yingjun Zhi, et al.
Oncotarget|September 30, 2015
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitorXing Yang, Il Minn, Steven P Rowe, et al.
Pageof 58